Cargando…

Editorial: Cancer neuroscience: Drug repurposing targeting the innervated niche

Detalles Bibliográficos
Autores principales:	Jin, Ming-Zhu, Gao, Xing-Chun, Jin, Wei-Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992969/ https://www.ncbi.nlm.nih.gov/pubmed/36909193 http://dx.doi.org/10.3389/fphar.2023.1148706

Ejemplares similares

Drug repurposing in cancer neuroscience: From the viewpoint of the autophagy-mediated innervated niche
por: Shi, Jiayan, et al.
Publicado: (2022)

Editorial: New Paradigms in Neuroscience and Related Targets for Drug Discovery
por: Salomone, Salvatore
Publicado: (2020)

Editorial: Drug Repurposing for COVID-19 Therapy
por: Maldonado, Rafael, et al.
Publicado: (2021)

Editorial: Drug repurposing and polypharmacology: A synergistic approach in multi-target based drug discovery
por: Rudrapal, Mithun, et al.
Publicado: (2022)

Editorial: The challenges of drug repurposing in diseases related to chronic inflammation
por: Collotta, Debora, et al.
Publicado: (2023)

Editorial: Translational Research and Drug Repurposing for Non-Communicable Diseases (NCDs)
por: Akindele, Abidemi J., et al.
Publicado: (2022)

Target-specific compound selectivity for multi-target drug discovery and repurposing
por: Wang, Tianduanyi, et al.
Publicado: (2022)

Screening of GPCR drugs for repurposing in breast cancer
por: Abdulkareem, Noor Mazin, et al.
Publicado: (2022)

Disulfiram in glioma: Literature review of drug repurposing
por: Zhong, Shiyu, et al.
Publicado: (2022)

On the Integration of In Silico Drug Design Methods for Drug Repurposing
por: March-Vila, Eric, et al.
Publicado: (2017)

Drug Repurposing for Targeting Acute Leukemia With KMT2A (MLL)—Gene Rearrangements
por: Tsakaneli, Alexia, et al.
Publicado: (2021)

Phenotypic screening of low molecular weight compounds is rich ground for repurposed, on-target drugs
por: Lipinski, Christopher A., et al.
Publicado: (2022)

A Comparative Study of Cluster Detection Algorithms in Protein–Protein Interaction for Drug Target Discovery and Drug Repurposing
por: Ma, Jun, et al.
Publicado: (2019)

“Hard” Drug Repurposing for Precision Oncology: The Missing Link?
por: Pantziarka, Pan, et al.
Publicado: (2018)

Challenges for Drug Repurposing in the COVID-19 Pandemic Era
por: Sultana, Janet, et al.
Publicado: (2020)

Drug Repurposing for Rare Diseases: A Role for Academia
por: van den Berg, Sibren, et al.
Publicado: (2021)

Fingolimod and Diabetic Retinopathy: A Drug Repurposing Study
por: Gesualdo, Carlo, et al.
Publicado: (2021)

A Database of Drug Repurposing Clinical Trials in Oncology
por: Pantziarka, Pan, et al.
Publicado: (2021)

Current Drug Repurposing Strategies for Rare Neurodegenerative Disorders
por: Shah, Sweta, et al.
Publicado: (2021)

Editorial: Drug Repurposing
por: Pantziarka, Pan, et al.
Publicado: (2019)

Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021
por: Alam, Safaet, et al.
Publicado: (2021)

Repurposing of Bromocriptine for Cancer Therapy
por: Seo, Ean-Jeong, et al.
Publicado: (2018)

Editorial: Metalloenzymes: Potential Drug Targets
por: Iqbal, Jamshed, et al.
Publicado: (2021)

The updated landscape of tumor microenvironment and drug repurposing
por: Jin, Ming-Zhu, et al.
Publicado: (2020)

Repurposing of Pirfenidone (Anti-Pulmonary Fibrosis Drug) for Treatment of Rheumatoid Arthritis
por: Gan, Donghao, et al.
Publicado: (2021)

Drug Repurposing of the Anthelmintic Niclosamide to Treat Multidrug-Resistant Leukemia
por: Hamdoun, Sami, et al.
Publicado: (2017)

Repurposing Cefazolin-Avibactam for the Treatment of Drug Resistant Mycobacterium tuberculosis
por: Srivastava, Shashikant, et al.
Publicado: (2021)

Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery
por: Li, Xinlei, et al.
Publicado: (2021)

Drug repurposing in cardiovascular inflammation: Successes, failures, and future opportunities
por: Chaffey, Laura, et al.
Publicado: (2022)

Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities
por: Porta, Exequiel O. J., et al.
Publicado: (2023)

Enrichment analysis of phenotypic data for drug repurposing in rare diseases
por: Ambesi-Impiombato, Alberto, et al.
Publicado: (2023)

Editorial: Anti-cancer effects of botanical drugs targeting the tumor microenvironment
por: Cheng, Chien-shan, et al.
Publicado: (2023)

Editorial: Orphan GPCRs As Emerging Drug Targets
por: Fang, Ye, et al.
Publicado: (2015)

Editorial: Cardio-Protection and Heart Repair: New Drugs, Targets and Approaches
por: Zagidullin, Naufal, et al.
Publicado: (2021)

Editorial: Drugging p53 for non-cancer diseases
por: Jiang, Fan, et al.
Publicado: (2022)

Repurposing Anti-Malaria Phytomedicine Artemisinin as a COVID-19 Drug
por: Uckun, Fatih M., et al.
Publicado: (2021)

Repurposing Artemisinin and its Derivatives as Anticancer Drugs: A Chance or Challenge?
por: Ma, Zhaowu, et al.
Publicado: (2021)

Drug repurposing candidates to treat core symptoms in autism spectrum disorder
por: Koch, Elise, et al.
Publicado: (2022)

Barbiturates and pyrazolopyridines for the treatment of postpartum depression—repurposing of two drug classes
por: Horwitz, Alexander B., et al.
Publicado: (2023)

Drug repurposing for Alzheimer’s disease from 2012–2022—a 10-year literature review
por: Grabowska, Monika E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1je3roe1g225h33qd377rvd7mj